This sector is capturing significant attention due to increasing prevalence rates and growing market opportunities. As awareness of cardiac amyloidosis rises, market dynamics are shifting with new therapeutic innovations shaping the industry landscape.

Market Size and Overview The Global Cardiac Amyloidosis Market is estimated to be valued at USD 6.51 Bn in 2025 and is expected to reach USD 10.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Investment Scenario Investment trends in the cardiac amyloidosis market reflect heightened venture capital interest and strategic mergers and acquisitions in 2025. Notably, significant funding rounds were secured by innovative biotech companies focusing on RNA-targeted therapies and monoclonal antibodies. For instance, Alnylam Pharmaceuticals reported increased capital allocation towards pipeline expansion and global market development in 2025. Additionally, AstraZeneca’s strategic partnerships and Ionis Pharmaceuticals’ collaborations to accelerate drug development have expanded market growth opportunities. The robust investment climate underscores growing confidence in breakthrough therapeutics as vital market growth strategies while addressing market challenges related to high R&D costs.

Regional Opportunities

• North America: Holds dominant industry share in 2025 due to strong healthcare infrastructure, favorable reimbursement policies, and early adoption of advanced diagnostic tools. The region is expected to sustain market momentum with the entry of new market players.
• Europe: The region benefits from government incentives and increasing export of novel therapeutics, particularly in Germany and France, enhancing cardiac amyloidosis market size and revenue in 2024-2025. Regulatory support accelerates market scope.
• Asia-Pacific: Emerging as a high-growth geography due to expanding healthcare infrastructure and rising patient awareness in countries like Japan and China. Recent government policies facilitating clinical trials and market access have created significant market opportunities for cardiac amyloidosis market players.

‣ Cardiac Amyloidosis Market: https://www.coherentmi.com/industry-reports/cardiac-amyloidosis-market